Research.Patient.info
Chronic Thromboembolic Pulmonary Hypertension, Pulmonary Arterial Hypertension research hub
2 indexed studies · 2 currently recruiting
- recruitingTherapeutic use (Phase IV)
An open-label, prospective, single centre study of the effects of Riociguat on RIght VEntricular size and function in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
This study looks at how a medicine called Riociguat affects the right side of the heart in people with pulmonary hypertension. Researchers want to see if it changes the size and function of the heart's right chambers over 24 weeks.
Germany - recruitingTherapeutic exploratory (Phase II)
Effects of DAPAgliflozin on cardiopulmonary exercise capacity and hemodynamics in Pulmonary Arterial Hypertension: A double blind randomized trial. (DAPAH-trial)
This study is looking at a medicine called Forxiga (dapagliflozin) for people with high blood pressure in their lungs (pulmonary hypertension). We want to see if it helps improve how well people can exercise and how their heart and lungs work.
Denmark